|
CZ285118B6
(cs)
|
1991-03-05 |
1999-05-12 |
The Wellcome Foundation Limited |
Exprese rekombinačních proteinů v oslabených bakteriích
|
|
US5961974A
(en)
|
1991-10-25 |
1999-10-05 |
Immunex Corporation |
Monoclonal antibodies to CD40 ligand, pharmaceutical composition comprising the same and hybridomas producing the same
|
|
DE69233051T2
(de)
|
1991-10-25 |
2004-03-11 |
Immunex Corp., Seattle |
Antikörper gegen CD40-L
|
|
US5962406A
(en)
|
1991-10-25 |
1999-10-05 |
Immunex Corporation |
Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
|
|
US7405270B2
(en)
|
1991-10-25 |
2008-07-29 |
Immunex Corporation |
CD40-Ligand lacking native-pattern glycosylation
|
|
US5716805A
(en)
|
1991-10-25 |
1998-02-10 |
Immunex Corporation |
Methods of preparing soluble, oligomeric proteins
|
|
US5981724A
(en)
|
1991-10-25 |
1999-11-09 |
Immunex Corporation |
DNA encoding CD40 ligand, a cytokine that binds CD40
|
|
US5540926A
(en)
|
1992-09-04 |
1996-07-30 |
Bristol-Myers Squibb Company |
Soluble and its use in B cell stimulation
|
|
CA2143299A1
(en)
|
1992-09-04 |
1994-03-17 |
University Of Saskatchewan |
Novel bacterial vaccines using vaccine strains of pathogenic bacteria
|
|
US5565321A
(en)
|
1993-01-22 |
1996-10-15 |
Immunex Corporation |
Detection of mutations in a CD40 ligand gene
|
|
AU1059095A
(en)
|
1993-11-24 |
1995-06-13 |
Australian National University, The |
Treatment of viral disease with cd40l peptide
|
|
ATE309267T1
(de)
|
1994-04-28 |
2005-11-15 |
Boehringer Ingelheim Pharma |
Methode zur proliferation und differenzierung von b-zellen und verwendungen dafür
|
|
AU699291B2
(en)
|
1995-03-01 |
1998-11-26 |
Immunex Corporation |
Method for stimulating an immune response
|
|
AU693713B2
(en)
|
1995-06-07 |
1998-07-02 |
Immunex Corporation |
CD40L mutein
|
|
US6479258B1
(en)
|
1995-12-07 |
2002-11-12 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines
|
|
US6713279B1
(en)
|
1995-12-07 |
2004-03-30 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines and enzymes
|
|
US6306387B1
(en)
|
1997-05-29 |
2001-10-23 |
The Research Foundation Of State University Of New York |
Antigen delivery system
|
|
US20030045492A1
(en)
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
|
US6969609B1
(en)
|
1998-12-09 |
2005-11-29 |
The United States Of America As Represented By The Department Of Health And Human Serivces |
Recombinant vector expressing multiple costimulatory molecules and uses thereof
|
|
CA2223225A1
(en)
|
1997-11-28 |
1999-05-28 |
Canadian Red Cross Society |
Method for inhibiting in vivo immune response
|
|
JP2001526241A
(ja)
|
1997-12-19 |
2001-12-18 |
イミュネックス・コーポレーション |
Ｈｉｖ感染に対する感受性を低下させるための方法
|
|
GB9806449D0
(en)
|
1998-03-25 |
1998-05-27 |
Peptide Therapeutics Ltd |
Attenuated bacteria useful in vaccines
|
|
US6190669B1
(en)
|
1998-05-13 |
2001-02-20 |
University Of Maryland, Baltimore |
Attenuated mutants of salmonella which constitutively express the Vi antigen
|
|
IT1299583B1
(it)
|
1998-05-19 |
2000-03-16 |
Vander Way Limited |
Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
|
|
PT1108034E
(pt)
|
1998-09-04 |
2008-11-14 |
Emergent Product Dev Uk Ltd |
Mutantes de spi2 de salmonela atenuados como transportadores de antigénios
|
|
US7300774B1
(en)
|
1999-12-09 |
2007-11-27 |
The Regents Of The University Of California |
Multimeric fusion proteins of the TNF superfamily ligands
|
|
EP1067194A1
(en)
|
1999-04-16 |
2001-01-10 |
F. Hoffmann-La Roche Ag |
Vectors containing a gene coding for CD40 and/or CD40L under the control of a cytokine-inducible promoter which is a human acute phase amyloid A gene promoter. Methods for their production and uses thereof
|
|
JP2003508016A
(ja)
|
1999-04-16 |
2003-03-04 |
エフ．ホフマン−ラ ロシュ アーゲー |
Ｃｄ４０／ｃｄ４０ｌキメラポリペプチドをコードする核酸、それらの生成方法及びそれらの使用
|
|
US7803765B2
(en)
|
1999-05-05 |
2010-09-28 |
Phylogica Limited |
Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
|
|
US7118751B1
(en)
|
1999-10-14 |
2006-10-10 |
Trubion Pharmaceuticals, Inc. |
DNA vaccines encoding antigen linked to a domain that binds CD40
|
|
ES2222152T3
(es)
|
1999-12-28 |
2005-02-01 |
Akzo Nobel N.V. |
Vacuna con las salmonellas que no inducen anticuerpos que reaccionan con la flagelina o los flagelos.
|
|
CA2399790C
(en)
|
2000-02-02 |
2012-10-30 |
Ralph A. Tripp |
Cd40 ligand adjuvant for respiratory syncytial virus
|
|
MXPA02008748A
(es)
|
2000-03-17 |
2003-02-24 |
Upjohn Co |
Materiales y metodos para vacuna antisalmonella.
|
|
GB0015426D0
(en)
|
2000-06-24 |
2000-08-16 |
Univ Southampton |
Method for generating soluble highly multimeric proteins
|
|
EP1299115A2
(en)
|
2000-06-26 |
2003-04-09 |
Maxygen, Inc. |
Methods and compositions for developing spore display systems for medicinal and industrial applications
|
|
WO2002036769A2
(en)
|
2000-10-31 |
2002-05-10 |
F. Hoffmann-La Roche Ag |
Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
|
|
HUP0500042A3
(en)
|
2001-05-15 |
2010-01-28 |
Long Island Jewish Res Inst |
Use of hmg fragments as anti-inflammatory agents
|
|
EP2687593A1
(en)
|
2001-05-15 |
2014-01-22 |
Ortho-McNeil Pharmaceutical, Inc. |
Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
|
|
US7220723B2
(en)
|
2001-05-15 |
2007-05-22 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
ZA200400479B
(en)
|
2001-07-06 |
2006-05-31 |
Abic Biolog Lab Teva |
Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
|
|
AU2002316560B2
(en)
|
2001-07-06 |
2008-05-01 |
Abic Biological Laboratories Ltd |
Nucleic acids encoding a recombinant 250 kDa antigen from Sporozoites/Merozoites of Eimeria maxima and their uses
|
|
ITMI20011986A1
(it)
|
2001-09-25 |
2003-03-25 |
San Raffaele Centro Fond |
Metodo e composizione per l'attivazione di cellule presentanti l'antigene
|
|
US7378089B2
(en)
|
2001-10-02 |
2008-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene therapy for the prevention of autoimmune disease
|
|
EP1453531B1
(de)
|
2001-12-19 |
2008-05-14 |
Alcedo Biotech GmbH |
Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren
|
|
AU2002359780B2
(en)
|
2001-12-21 |
2009-08-13 |
Immunex Corporation |
Recombinant polypeptides
|
|
KR100965026B1
(ko)
|
2002-02-13 |
2010-06-21 |
이뮤놀로지 래보러토리스 인코포레이티드 |
미생물 감염증을 치료하기 위한 조성물 및 방법
|
|
US6923958B2
(en)
|
2002-03-02 |
2005-08-02 |
The Scripps Research Institute |
DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
|
|
US8133493B2
(en)
|
2002-04-15 |
2012-03-13 |
Washington University |
Regulated attenuation of live vaccines to enhance cross-protective immunogenicity
|
|
US7495090B2
(en)
|
2002-05-23 |
2009-02-24 |
The Regents Of The University Of California |
Nucleic acids encoding chimeric CD154 polypeptides
|
|
US20040156851A1
(en)
|
2002-11-20 |
2004-08-12 |
Critical Therapeutics, Inc. |
HMGB1 combination therapies
|
|
US20040141948A1
(en)
|
2002-11-20 |
2004-07-22 |
Critical Therapeutics, Inc. |
Use of HMGB fragments as anti-inflammatory agents
|
|
JP2006510619A
(ja)
|
2002-11-20 |
2006-03-30 |
クリティカル セラピューティクス，インコーポレイテッド |
抗炎症剤としてのｈｍｇｂ断片の使用
|
|
EP1567544A4
(en)
|
2002-11-20 |
2009-07-22 |
Long Island Jewish Res Inst |
USE OF HMGB POLYPEPTIDES TO IMPROVE THE IMMUNE REACTIONS
|
|
US20060014248A1
(en)
|
2003-01-06 |
2006-01-19 |
Xencor, Inc. |
TNF super family members with altered immunogenicity
|
|
US20050181994A1
(en)
|
2003-01-06 |
2005-08-18 |
Xencor, Inc. |
Novel variants of CD40L protein
|
|
US7696169B2
(en)
|
2003-06-06 |
2010-04-13 |
The Feinstein Institute For Medical Research |
Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
|
|
US7754209B2
(en)
|
2003-07-26 |
2010-07-13 |
Trubion Pharmaceuticals |
Binding constructs and methods for use thereof
|
|
WO2005025604A2
(en)
|
2003-09-10 |
2005-03-24 |
The General Hospital Corporation |
Use of hmgb and hmgb fragments to decrease specific immune response
|
|
WO2005035570A2
(en)
|
2003-10-10 |
2005-04-21 |
Xencor, Inc. |
Variants of cd40l protein
|
|
CA2548347A1
(en)
|
2003-12-11 |
2005-06-30 |
Sidney Kimmel Cancer Center |
Methods for generating immunity to antigen
|
|
US8828957B2
(en)
|
2003-12-11 |
2014-09-09 |
Microvax, Llc |
Methods for generating immunity to antigen
|
|
WO2005113598A2
(en)
|
2004-05-21 |
2005-12-01 |
Xencor, Inc. |
Tnf super family members with altered immunogenicity
|
|
WO2006083301A2
(en)
|
2004-06-17 |
2006-08-10 |
Medimmune, Inc. |
Immunogenic compositions comprising hmgb1 polypeptides
|
|
WO2006012373A2
(en)
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Combination therapies of hmgb and complement inhibitors against inflammation
|
|
CN101044160A
(zh)
*
|
2004-08-19 |
2007-09-26 |
蛋白质组系统知识产权有限公司 |
结核分支杆菌感染的诊断和治疗方法及所用试剂
|
|
CN101080487B
(zh)
|
2004-10-07 |
2012-11-14 |
阿戈斯治疗公司 |
成熟树突细胞组合物及其培养方法
|
|
US8513008B2
(en)
|
2004-10-07 |
2013-08-20 |
Argos Therapeutics, Inc. |
Mature dendritic cell compositions and methods for culturing same
|
|
WO2006105972A1
(en)
|
2005-04-07 |
2006-10-12 |
Universite Libre De Bruxelles |
Transgenic organism expressing cd40l and uses thereof
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
US20060286074A1
(en)
|
2005-05-31 |
2006-12-21 |
Yucheng Tang |
Methods for immunotherapy of cancer
|
|
EP1909834A2
(en)
|
2005-07-18 |
2008-04-16 |
Critical Therapeutics, Inc. |
Use of hmgb1 antagonists for the treatment of inflammatory skin conditions
|
|
PL1949913T3
(pl)
|
2005-10-07 |
2010-10-29 |
Proyecto De Biomedicina Cima S L |
Immunostymulująca kombinacja do profilaktyki i leczenia wirusowego zapalenia wątroby typu c
|
|
CA2628837C
(en)
|
2005-11-07 |
2018-11-27 |
Sidney Kimmel Cancer Center |
Cd40 ligand fusion protein vaccine
|
|
WO2007054658A1
(en)
|
2005-11-14 |
2007-05-18 |
King's College London |
Control of immune responses
|
|
WO2007130725A2
(en)
|
2006-02-06 |
2007-11-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Use of hmgb1 for protection against ischemia reperfusion injury
|
|
WO2007103048A2
(en)
|
2006-03-01 |
2007-09-13 |
Regents Of The University Of Colorado |
Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
|
|
US8802419B2
(en)
|
2006-03-02 |
2014-08-12 |
University Of Massachusetts |
Modified pathogens for use as vaccines
|
|
US8604178B2
(en)
|
2006-09-18 |
2013-12-10 |
The Board Of Trustees Of The University Of Arkansas |
Compositions and methods of enhancing immune responses
|
|
WO2008109825A2
(en)
|
2007-03-08 |
2008-09-12 |
Mayo Foundation For Medical Education And Research |
Inducing immune-mediated tumor cell death
|
|
CN101024076B
(zh)
|
2007-03-29 |
2010-08-18 |
中国农业大学 |
球虫的新用途
|
|
US9125854B2
(en)
|
2007-10-30 |
2015-09-08 |
The Board Of Trustees Of The University Of Arkansas |
Compositions and methods of enhancing immune responses to flagellated bacterium
|
|
PL3097926T3
(pl)
*
|
2007-11-01 |
2020-04-30 |
The Board Of Trustees Of The University Of Arkansas |
Kompozycje i sposoby wzmacniania odpowiedzi odpornościowych na Eimeria
|
|
CN101234196A
(zh)
|
2007-11-30 |
2008-08-06 |
吉林大学 |
球虫重组卡介苗及制备方法
|
|
DK2329266T3
(en)
|
2008-09-11 |
2016-07-18 |
Pasteur Institut |
MONITORING AND INHIBITING INFECTION WITH HUMAN IMMUNE DEFECT VIRUS BY MODULATING HMGB1-DEPENDENT TRACTOR OF HIV-1 REPLICATION AND PERSISTENCE
|
|
MX2011005133A
(es)
|
2008-11-13 |
2011-08-04 |
Intervet Int Bv |
Vacuna contra eimeria para pavos.
|
|
US20100150958A1
(en)
|
2008-12-15 |
2010-06-17 |
Vectogen Pty Ltd. |
Methods and Compositions for Use of a Coccidiosis Vaccine
|
|
JP2011072284A
(ja)
*
|
2009-10-01 |
2011-04-14 |
Mitsubishi Chemicals Corp |
抗体の製造方法及びそれに用いる免疫原性組成物
|
|
HUE037157T2
(hu)
*
|
2010-01-21 |
2018-08-28 |
Univ Arkansas |
Vakcinavektorok, és eljárások immunválaszok fokozására
|
|
KR102008120B1
(ko)
|
2010-06-09 |
2019-08-07 |
더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 |
캄필로박터 감염을 감소시키기 위한 백신 및 방법
|
|
CN104884069B
(zh)
|
2012-10-29 |
2018-11-27 |
阿肯色大学评议会 |
新的黏膜佐剂和递送系统
|
|
EA030929B1
(ru)
|
2013-02-14 |
2018-10-31 |
Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Арканзас |
КОМПОЗИЦИИ И СПОСОБЫ УСИЛЕНИЯ ИММУННЫХ ОТВЕТОВ НА Eimeria ИЛИ ОГРАНИЧЕНИЯ ИНФЕКЦИИ Eimeria
|
|
BR112015023024B1
(pt)
|
2013-03-15 |
2022-04-19 |
The Board Of Trustees Of The University Of Arkansas |
Vetor de vacina e composições farmacêuticas compreendendo o mesmo
|